Eye-catching cancer drug trial results have researchers asking: What’s next?

After a small cancer drug study yielded the unprecedented result of 100 percent of participants entering remission, oncologists — and patients — wonder if the approach from the experimental drug trial can apply to other types of cancer.

The study out of Memorial Sloan Kettering Cancer Center in New York has oncologists excited over the prospect that immunotherapy, the treatment type used in the trial, has increasingly shown effectiveness — without surgery

Read More